557 related articles for article (PubMed ID: 15449939)
1. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
2. Functional cartography of the ectodomain of the type I interferon receptor subunit ifnar1.
Lamken P; Gavutis M; Peters I; Van der Heyden J; Uzé G; Piehler J
J Mol Biol; 2005 Jul; 350(3):476-88. PubMed ID: 15946680
[TBL] [Abstract][Full Text] [Related]
3. Determination of residues involved in ligand binding and signal transmission in the human IFN-alpha receptor 2.
Chuntharapai A; Gibbs V; Lu J; Ow A; Marsters S; Ashkenazi A; De Vos A; Jin Kim K
J Immunol; 1999 Jul; 163(2):766-73. PubMed ID: 10395669
[TBL] [Abstract][Full Text] [Related]
4. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
Piehler J; Schreiber G
J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
[TBL] [Abstract][Full Text] [Related]
5. NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.
Chill JH; Quadt SR; Anglister J
Biochemistry; 2004 Aug; 43(31):10127-37. PubMed ID: 15287740
[TBL] [Abstract][Full Text] [Related]
6. Shared receptor components but distinct complexes for alpha and beta interferons.
Lewerenz M; Mogensen KE; Uzé G
J Mol Biol; 1998 Sep; 282(3):585-99. PubMed ID: 9737924
[TBL] [Abstract][Full Text] [Related]
7. Structure-function study of the extracellular domain of the human IFN-alpha receptor (hIFNAR1) using blocking monoclonal antibodies: the role of domains 1 and 2.
Lu J; Chuntharapai A; Beck J; Bass S; Ow A; De Vos AM; Gibbs V; Kim KJ
J Immunol; 1998 Feb; 160(4):1782-8. PubMed ID: 9469437
[TBL] [Abstract][Full Text] [Related]
8. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
9. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
Lamken P; Lata S; Gavutis M; Piehler J
J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
[TBL] [Abstract][Full Text] [Related]
10. The IFNAR1 subunit of the type I IFN receptor complex contains a functional nuclear localization sequence.
Subramaniam PS; Johnson HM
FEBS Lett; 2004 Dec; 578(3):207-10. PubMed ID: 15589821
[TBL] [Abstract][Full Text] [Related]
11. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
12. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
13. Variations in the unstructured C-terminal tail of interferons contribute to differential receptor binding and biological activity.
Slutzki M; Jaitin DA; Yehezkel TB; Schreiber G
J Mol Biol; 2006 Jul; 360(5):1019-30. PubMed ID: 16815442
[TBL] [Abstract][Full Text] [Related]
14. Mapping human interferon-alpha (IFN-alpha 2) binding determinants of the type I interferon receptor subunit IFNAR-1 with human/bovine IFNAR-1 chimeras.
Goldman LA; Cutrone EC; Dang A; Hao X; Lim JK; Langer JA
Biochemistry; 1998 Sep; 37(37):13003-10. PubMed ID: 9737881
[TBL] [Abstract][Full Text] [Related]
15. Post-translational up-regulation of the cell surface-associated alpha component of the human type I interferon receptor during differentiation of peripheral blood monocytes: role in the biological response to type I interferon.
Eantuzzi L; Eid P; Malorni W; Rainaldi G; Gauzzi MC; Pellegrini S; Belardelli F; Gessani S
Eur J Immunol; 1997 May; 27(5):1075-81. PubMed ID: 9174595
[TBL] [Abstract][Full Text] [Related]
16. A structural basis for interferon-alpha-receptor interactions.
Kumaran J; Wei L; Kotra LP; Fish EN
FASEB J; 2007 Oct; 21(12):3288-96. PubMed ID: 17517919
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.
Arduini RM; Strauch KL; Runkel LA; Carlson MM; Hronowski X; Foley SF; Young CN; Cheng W; Hochman PS; Baker DP
Protein Sci; 1999 Sep; 8(9):1867-77. PubMed ID: 10493588
[TBL] [Abstract][Full Text] [Related]
18. Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.
Jaitin DA; Roisman LC; Jaks E; Gavutis M; Piehler J; Van der Heyden J; Uze G; Schreiber G
Mol Cell Biol; 2006 Mar; 26(5):1888-97. PubMed ID: 16479007
[TBL] [Abstract][Full Text] [Related]
19. The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening.
Chill JH; Nivasch R; Levy R; Albeck S; Schreiber G; Anglister J
Biochemistry; 2002 Mar; 41(11):3575-85. PubMed ID: 11888273
[TBL] [Abstract][Full Text] [Related]
20. Formation of a uniquely stable type I interferon receptor complex by interferon beta is dependent upon particular interactions between interferon beta and its receptor and independent of tyrosine phosphorylation.
Russell-Harde D; Wagner TC; Perez HD; Croze E
Biochem Biophys Res Commun; 1999 Feb; 255(2):539-44. PubMed ID: 10049744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
